Seres has finalized the protocol for the Phase 2 study of SER-155 in patients undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT) with the FDA and has advanced key study startup ...
BEIJING - The Shanghai, Shenzhen and Beijing stock exchanges on Monday announced a package of measures to optimize refinancing rules to support high-quality listed companies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results